In My Practice A man in his forties came into clinic last year with classic renal colic three weeks after his tirzepatide dose was stepped up
Patients with type 2 diabetes, especially those with cardiovascular disease, chronic kidney disease, obesity, or NAFLD, may benefit from GLP-1 receptor agonists as part of their treatment regimen
Science 308 , 16351638 (2005)
For researchers running dose-escalation studies or comparing multiple dosing regimens simultaneously, smaller vial sizes (5mg/5mg or 6mg/6mg) offer flexibilityeach subject cohort can be assigned a dedicated vial, minimizing cross-contamination risk and simplifying dose tracking
As body weight decreases, patients may experience better energy, improved confidence, reduced strain on joints, and better control of weight-related health concerns
Mild to severe side effects can occur, and you should report them to your doctor and healthcare team